Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
The Scientist
Most Recent
The scientific community and the impact of the Myriad Genetics Supreme Court decision
Supreme Court says no patenting (natural) genes; brain-computer interfaces mimic motor learning in brain; regenerating finger tips; gene therapy goes deeper; NIH needs more diversity; cross-border collaboration
The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.
Researchers identify the signaling program that enables finger and toenail stem cells to direct digit regeneration after amputation.
US universities need to reach across their own borders to retain global scientific preeminence.
The NIH remains a Caucasian-dominated workforce. Why haven’t the agency’s efforts to diversify been successful?
In avian species, a gene induces programmed cell death during development in the area where a phallus would otherwise grow.
Top justices rule that police have the right to take DNA swabs from people who are arrested, even before they are convicted.
Take a closer look at some of the statistics generated by The Scientist's Best Place to Work Industry 2013 survey.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
